Delivery Order SPE2DB20D1109-SPE2DB25FN36C
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,287.74 contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,958.34, is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML medical supplies. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a larger...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,067.60, is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a firm-fixed-price contract with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,358.92, is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical supplies. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,688.07, is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,136.72, is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,136.64 Firm Fixed Price Delivery Order contract is to provide ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product, to the DLA. The contract has an ultimate completion date of April 1, 2025. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,016.68, is for the provision of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical products. The contract is a firm fixed-price delivery order with an ultimate completion date of December 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,202.60 firm fixed-price contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.8ML, a medical product, with an ultimate completion date of January 21, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,287.74, is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FN36CDelivery Order
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,440.74, is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical supplies. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/6/25 |